Strand AI logo

Strand AI

Multimodal foundation models to predict uncollected patient biology

Winter 2026Healthcare / Healthcare -> Drug Discovery and DeliverySan Francisco, CA, USA2 employees

About

Strand AI develops foundation models to generate missing bio-data about patients. With this imputed data, pharmaceutical companies can select better patients for their drug trials and shave months from their drug launch timelines. We’ve already trained a multimodal foundation model that integrates spatial biology modalities, beating SOTA at a fraction of the cost.

Build your own investing agent

GPAgent keeps YC listings public and neutral. Fund-specific scoring, notes, and workflow state live in each customer workspace.

Join the GPAgent waitlist

Founders (2)

Oded Falik
Founder
Yue Dai
Founder

Details

Status
Active
Stage
Early
Team Size
2
Regions
United States of America, America / Canada